drugset / Trial / NCT01570504

Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis

NCT01570504 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Ivermectin is currently the best drug to cure strongyloidiasis, but the "standard" single dose of 200 mcg/kg is probably not enough to guarantee cure. As strongyloidiasis can be fatal in immunosuppressed patients, it is mandatory to define the optimal dosage to eradicate the parasite. Aim of this study is to define the most effective dose schedule of ivermectin to cure strongyloidiasis.

Timeline

Start
2013-03
Primary completion
2018-06-08
Completion
2018-06-08

Outcome

Missed primary endpoint

paper risk difference 1·48%, 95% CI -7·55 to 10·52; p=0·75 PMID 31558376 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule 200 ug/kg Oral

Indications